Screening thep53 status of human cell lines using a yeast functional assay
- 1 August 1997
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 19 (4) , 243-253
- https://doi.org/10.1002/(sici)1098-2744(199708)19:4<243::aid-mc5>3.0.co;2-d
Abstract
We have screened the p53 status of 156 human cell lines, including 142 tumor cell lines from 27 different tumor types and 14 cell lines from normal tissues by using functional analysis of separated alleles in yeast. This assay enables us to score wild‐type p53 expression on the basis of the ability of expressed p53 to transactivate the reporter gene HIS3 via the p53‐responsive GAL1 promoter in Saccharomyces cerevisiae. Of 142 tumor cell lines, at least 104 lines (73.2%) were found to express the mutated p53 gene: 94 lines (66.2%) were mutated in both alleles, three lines (2.1%) were heterozygous, and no p53 cDNA was amplified from seven lines (4.9%). Of the 14 cell lines originating from normal tissues, all the transformed or immortalized cell lines expressed mutant p53 only. Yeast cells expressing mutant p53 derived from 94 cell lines were analyzed for temperature‐sensitive growth. p53 cDNA from eight cell lines showed p53‐dependent temperature‐sensitive growth, growing at 30°C but not at 37°C. Four temperature‐sensitive p53 mutations were isolated: CAT→CGT at codon 214 (H214R), TAC→TGC at codon 234 (Y234C), GTG→ATG at codon 272 (V272M), and GAG→AAG (E285K). Functionally wild‐type p53 was detected in 38 tumor cell lines (26.8%) and all of the diploid fibroblasts at early and late population doubling levels. These results strongly support the previous findings that p53 inactivation is one of the most frequent genetic events that occurs during carcinogenesis and immortalization. Mol. Carcinog. 19:243–253, 1997.Keywords
This publication has 45 references indexed in Scilit:
- Mutation inp53 and de-regulation ofp53-related gene expression in three human cell lines immortalized with 4-nitroquinoline 1-oxide or60Co gamma raysInternational Journal of Cancer, 1996
- The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus ImmunohistochemistryJNCI Journal of the National Cancer Institute, 1996
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism methodZeitschrift für Krebsforschung und Klinische Onkologie, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell linesCarcinogenesis: Integrative Cancer Research, 1993
- Missense mutations and a deletion of the p53 gene in human gastric cancerBiochemical and Biophysical Research Communications, 1992
- p53 Mutations in Human CancersScience, 1991
- Temperature-dependent switching between “wild-type” and “mutant” forms of p53-Val135Journal of Molecular Biology, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989